Étienne Chatelut
Impact in
Papers in
- Oncology 84
- Cancer Treatment and Pharmacology 33
- Colorectal Cancer Treatments and Studies 19
- Lung Cancer Research Studies 13
-
- Cancer therapeutics and mechanisms 34
- Co-authors
- Pierre Canal (61 shared papers)R. Bugat (32 shared papers)Gareth J. Veal (7 shared papers)Fabienne Thomas (36 shared papers)Angélo Paci (7 shared papers)Florent Puisset (20 shared papers)Dominique Levêque (3 shared papers)Jos H. Beijnen (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (29 papers)Journal of Clinical Oncology (15 papers)European Journal of Cancer (14 papers)Clinical Pharmacokinetics (9 papers)British Journal of Clinical Pharmacology (8 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Étienne Chatelut
231 papers receiving 6.7k citations
Peers
Comparison fields: 5 of 127
- Oncology 2.2k
- Genetics 554
- Pharmacology 466
- Hematology 528
- Nephrology 305
Countries citing papers authored by Étienne Chatelut
This map shows the geographic impact of Étienne Chatelut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Étienne Chatelut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Étienne Chatelut more than expected).
Fields of papers citing papers by Étienne Chatelut
This network shows the impact of papers produced by Étienne Chatelut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Étienne Chatelut. The network helps show where Étienne Chatelut may publish in the future.
Co-authors
The 25 scholars most cited alongside Étienne Chatelut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 240 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 407 | |
| 2 | 2014 | 248 | |
| 3 | 2014 | 221 | |
| 4 | 1995 | 202 | |
| 5 | 2007 | 182 | |
| 6 | 2007 | 167 | |
| 7 | 2007 | 143 | |
| 8 | 2006 | 132 | |
| 9 | 1998 | 131 | |
| 10 | 2010 | 130 | |
| 11 | 1993 | 129 | |
| 12 | 2008 | 127 | |
| 13 | 1999 | 121 | |
| 14 | 2007 | 108 | |
| 15 | 2006 | 104 | |
| 16 | Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patients. | 1994 | 95 |
| 17 | 2018 | 89 | |
| 18 | 2014 | 77 | |
| 19 | 1998 | 75 | |
| 20 | 1998 | 73 |
About Étienne Chatelut
Étienne Chatelut is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 240 papers that have together received 7.0k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (37 papers), Cancer therapeutics and mechanisms (34 papers), Cancer Treatment and Pharmacology (33 papers), Colorectal Cancer Treatments and Studies (19 papers), Pharmacogenetics and Drug Metabolism (16 papers), Lung Cancer Research Studies (13 papers), Intraperitoneal and Appendiceal Malignancies (13 papers) and Chronic Lymphocytic Leukemia Research (13 papers). The work is most often cited by research in Oncology (2.2k citations), Genetics (554 citations), Pharmacology (466 citations), Hematology (528 citations) and Nephrology (305 citations). Étienne Chatelut has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Pierre Canal, R. Bugat, Gareth J. Veal, Fabienne Thomas, Angélo Paci, Florent Puisset, Dominique Levêque, Jos H. Beijnen, A. Astier and Nicolas Widmer. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, European Journal of Cancer, Clinical Pharmacokinetics and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.